Arginine reduced the buildup of an Alzheimer’s-related protein in laboratory and animal experiments, giving scientists a potential treatment lead. The work also found improvements in some behavioral measures, but the approach has yet to show benefit in people with Alzheimer’s disease. Researchers at Kindai University studied whether the amino acid could interfere with amyloid-beta, a […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.